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Abstract
Staphylococcus aureus infections are associated with diverse clinical manifestations leading to significant morbidity and
mortality. To define the role of the host response in the clinical manifestations of the disease, we characterized whole blood
transcriptional profiles of children hospitalized with community-acquired S. aureus infection and phenotyped the bacterial
strains isolated. The overall transcriptional response to S. aureus infection was characterized by over-expression of innate
immunity and hematopoiesis related genes and under-expression of genes related to adaptive immunity. We assessed
individual profiles using modular fingerprints combined with the molecular distance to health (MDTH), a numerical score of
transcriptional perturbation as compared to healthy controls. We observed significant heterogeneity in the host signatures
and MDTH, as they were influenced by the type of clinical presentation, the extent of bacterial dissemination, and time of
blood sampling in the course of the infection, but not by the bacterial isolate. System analysis approaches provide a new
understanding of disease pathogenesis and the relation/interaction between host response and clinical disease
manifestations.
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Introduction
Staphylococcus aureus has emerged as one of the most frequent
cause of community-acquired invasive bacterial infections, with
significant morbidity and mortality. Just in 2005 in the United
States, 18,650 deaths were reported due to methicillin-resistant S.
aureus (MRSA) [1,2,3,4,5,6]. The spectrum of community-
associated (CA) S. aureus disease is wide and patients can present
with a variety of clinical illness, ranging from mild soft tissue
infections to invasive disease such as bacteremia, pneumonia, or
osteoarticular infections [1,7,8]. The emergence of multidrug
resistant S. aureus strains worldwide [9,10] combined with limited
therapeutic options demand novel approaches to further elucidate
host-pathogen interactions, and especially host responses to S.
aureus infection. Circulating leukocytes represent an accessible
source of molecular information, which can be studied by
analyzing the whole blood genome-wide transcriptome. The value
of blood microarray analysis has been illustrated in infection,
cancer and autoimmunity [11,12,13,14], leading to diagnostic and
therapeutic advances [14].
We have previously used microarray analysis to characterize the
differences in host responses to different microbial pathogens [11]
including S. aureus (Ardura et al, 2009) by analyzing peripheral
blood mononuclear cells (PBMC) from pediatric patients hospi-
talized with acute infections. The neutrophil depletion from
PBMC may result in the loss of key information in the systemic
characterization of bacterial infections [15]. As new research tools
became available we performed whole blood microarray profiling
–including neutrophils – in a new cohort of 99 pediatric patients
with S aureus infection. Using this large cohort we now defined: a)
the common host response to S aureus infection; and b) the
differences in host response patterns depending on the site of
infection and the clinical presentation of the disease. The main
objective of this analysis was to determine whether the
transcriptional profiles reflect the variation of clinical disease
manifestations and to provide new insights in disease pathogenesis
by defining the differences in host responses among patients with
different clinical presentations.
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S. aureus induces a distinct and robust transcriptional
signature in whole blood
To define the whole blood biosignature of S. aureus infection in
children, 99 patients and 44 healthy controls were assigned to two
independent groups of subjects, to serve as ‘‘training’’ and ‘‘test’’
sets. The training set was used to identify the signature of S. aureus
infection. This signature was validated in the independent test set
by assessing its capacity to separate the patients from healthy
controls by hierarchical clustering. The training set included 40
patients with S. aureus infection and 22 healthy controls, matched
for age, sex and race (Table 1). Statistical group comparison
yielded 1,422 differentially regulated transcripts. Hierarchical
clustering of these transcripts grouped them according to
similarities in gene expression patterns (Figure 1A). This signature
was validated in the independent test set of 59 patients and 22
healthy controls (Figure 1B). Hierarchical clustering of these 1,422
transcripts grouped 52 out of 59 patients from the test set together.
The seven patients who clustered with controls presented with
either mild or moderate disease, and were closer to recovery and
hospital discharge compared with all other patients.
S. aureus infection activates innate immunity and
suppresses the adaptive immune response
To better understand the whole blood response to S. aureus
infection and the immune pathways activated, we used an analytical
framework of 62 transcriptional modules that group together genes
withsharedexpression patternandsimilarbiological functionacross
independent blood transcriptional datasets [16]. Module maps were
derived independently for the training (Figure 1C) and test sets
(Figure 1D), using their respective healthy control group as
reference. Patients with acute S. aureus infection demonstrated
significant over-expression of modules linked to the myeloid lineage
(M3.2, M4.6, M4.13, M4.14, M6.6), and inflammation (M4.2,
M5.1, M6.13) confirming our earlier findings in PBMC. Further-
Table 1. Demographic and laboratory characteristics of patients and healthy controls in training and test sets.
Parameter TRAINING SET TEST SET
Patients Controls p
a Patients Controls p
a
Count 40 22 59 22
Age (years) 8.00 [0.15–17] 7.0 [4–18] 0.865 6.50 [0.06–16] 3 [0.17–14.00] 0.03
Race 19AA,12H,9C 6AA,11H,4C,1O 0.156 19AA,18H,15C,7O 1AA,13H,6C,2O 0.018
Gender 20M,20F 12M,10F 0.795 34M,25F 11M,11F 0.805
WBC (10
3/mm
3) 9.3 [4.1–28.1] 6.8[3.40–12.6] 0.006 10.10[3.20–33.3] 9.1 [4.20–16.0] 0.065
Neutrophils (%) 52.0 [15–87] 50.7 [34.7–59.8] 0.536 55.00[12.0–84] 35.0 [10.0–55.00] ,0.001
Neutrophils (10
3/
mm
3)
5.20 [1.16–22.4] 3.58[1.46–6.94] 0.025 5.63[0.74–18.1] 3.0 [0.84–7.76] ,0.001
Lymphocytes (%) 28.50 [5–67] 37.0 [29.4–53.8] 0.073 33.00 [5.00–72.0] 55.0[33.2–81.0] ,0.001
Lymphocytes (10
3/
mm
3)
2.70[0.93–11.0] 2.72 [1.29–4.36] 0.721 3.42 [0.44–13.3] 5.3 [1.44–11.2] 0.016
Monocytes (%) 7.50[1–21] 7.30[5.00–10.6] 0.775 8.0 [2–17] 5.6 [2.00–9.0] 0.096
Monocytes (10
3/
mm
3)
0.83 [0.08–3.40] 0.48 [0.19–0.72] 0.036 0.75 [0.14–3.49] 0.44 [0.30–0.98] 0.01
RBC (10
6/mm3) 3.92 [2.6–4.7] 3.90[3.40–4.03] 0.507 4.05 [1.27–5.65] no data
Hemoglobin 10.5 [7.3–13.7] 8.80[7.90–11.40] 0.1 10.60 [3.4–13.7] 12.60*
Hematocrit (%) 31.70 [22.1–38.6] 27.25[25.90–33.30] 0.13 31.70[11.1–40.3] 36.6*
MCV (um
3) 80.90 [70.7–88.9] 73.50[67.00–86.00] 0.083 81.00 [56.8–97.6] no data
MCH (pg) 27.30 [22.9–29.8] 23.75[20.40–29.30] 0.03 27.00 [17.9–33.4] no data
MCHC (g/dL) 33.6 [31–35.7] 32.05[30.40–34.20] 0.015 33.5 [30.6–35.9] no data
RDW (%) 13.40[11.8–19.4] 12.75[11.50–14.90] 0.337 13.30 [11.6–17.6] no data
MPV 9.30 [7.7–15] 7.80[6.50–10.00] 0.009 9.50 [7.8–12.4] no data
Platelets (10
3/mm
3) 412 [83–880] 261.00[214.00–288.00] 0.005 414.00 [136–833] 335.00*
ESR 67.00 [15–142] no data 68.00 [8–135] no data
CRP (mg/dL) 5.95 [0.1–37.4] no data 4.30 [0.1–42.8] no data
Hospitalization
Duration
11.00 [5–98] n/a 9.00 [1–53.00] n/a
Draw Day 5.00 [2–16] n/a 5.00 [1–35] n/a
Draw Index 0.43 [0.04–1] n/a 0.50 [0.08–1] n/a
Median values [min-max range]; AA=African-American, C=Caucasian, H=Hispanic, O=Other; M=Male, F=Female; WBC=White Blood Count; RBC=Red Blood Cell
count; MCV=Mean Corpuscular Volume; MCH=Mean Corpuscular Hemoglobin; MCHC=Mean Corpuscular Hemoglobin Concentration; RDW=Red blood cell
Distribution Width; MPV=Mean Platelet Volume; ESR=Erythrocyte Sedimentation Rate; CRP=C-reactive Protein;
*only 1 sample.
Statistics: for categorical variables, Fisher’s exact test is used; for continuous variables, Mann-Whitney test is used.
doi:10.1371/journal.pone.0034390.t001
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coagulation cascade (M1.1), hematopoietic precursors (M3.3 and
M5.3), and neutrophils (M5.15). Conversely, they demonstrated
significant under-expression of modules linked to T cells (M4.1,
M6.15and M6.19),cytotoxicity/NKcells(M3.6and M4.15),B cells
(M4.10), and lymphoid lineage (M4.7 and M6.9). Transcript
composition of these modules is summarized online (http://www.
biir.net/public_wikis/module_annotation/V2_Trial_8_Modules).
These findings were confirmed in the test set as shown by significant
correlation of module expression between training and test sets
(Figure 1F, p,0.0001, Spearman R=0.94) demonstrating the
consistency of these observations.
The blood signature of S. aureus infection demonstrates
significant heterogeneity
As the clinical presentation of individual patients was diverse,
once we defined the global whole blood response to S. aureus
infection, we then aimed to characterize how the variation in
anatomical site, dissemination of the infection and bacterial isolate
(Table 2) affect the signatures. Because the training and test sets
yielded similar modular fingerprints (Figure 1F), they were merged
into one dataset for subsequent analysis.
Our initial step was to examine the heterogeneity in the
signatures and then determine which factors could be associated
with such variation. To this end, we first calculated the molecular
distance to health, or MDTH for each individual patient. The
MDTH is a score that measures the global transcriptional
perturbation in each patient compared to the median of healthy
controls. Thus by summarizing the overall transcriptional activity in
one score, the MDTH facilitates the correlation with clinical
parameters [12,17]. Overall, as expected, the median MDTH of
patients was significantly higher than that of healthy controls
(Figure 2A,p,0.001).However,25patientshadMDTHscoresthat
were within the range of healthy controls MDTH (3–259). These
patients were flagged as transcriptionally quiescent (TQ) and
separated from transcriptionally active patients (n=74). Unsuper-
vised hierarchical clustering of the 10,972 transcripts expressed in at
Figure 1. The S. aureus infection whole blood transcriptional signature is characterized by over-expression of myeloid lineage
transcripts and under-expression of lymphoid lineage transcripts. A. Statistical group comparison between 22 healthy subjects and 40
patients with acute S. aureus infection (non-parametric test, a=0.01, Benjamini-Hochberg multiple testing correction, 1.25 fold change) yielded 1,422
differentially expressed transcripts. Transcripts were organized by hierarchical clustering (Spearman) according to similarities in expression profiles.
Each row represents a transcript and each column an individual subject. Normalized log ratio levels are indicated by red (over-expressed) or blue
(under-expressed), as compared to the median of healthy controls. B. The same 1,422 transcript list and hierarchical clustering were applied to an
independent test set of 22 healthy controls and 59 patients with acute S. aureus infection. Sample hierarchical clustering (Spearman) was performed
on the 1,422 transcript list in the test set. C. Average modular transcriptional fingerprrint for S. aureus patients as compared to healthy controls in the
training set. D. Average modular transcriptional profile for S. aureus patients as compared to healthy controls in the test set. E. Module functional
annotations legend. F. Scatter plot comparing module expression between training (x-axis) and test (y-axis) sets. Spearman correlation was applied.
doi:10.1371/journal.pone.0034390.g001
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healthy controls (Figure 2B). When analyzed from a clinical
perspective the majority of these patients presented with mild and
local infections with low C-reactive protein (CRP) and the samples
were obtained late in the course of the infection as reflected by an
elevated mean draw index (0.64) (see methods).
To assess the qualitative heterogeneity of transcriptionally active
patients (n=74; MDTH scores .259), individual modular
fingerprints were derived and k-means clustering was used to
further identify modular expression patterns. Four major tran-
scriptional active patient clusters (C1 to C4) were identified
(Figure 2C, Figure 2D) [18] (Figure S3). Group module expression
was derived for each cluster (Figure S4). Cluster C1 included 13
patients with a high mean MDTH (3,003) and strong over-
expression of myeloid (M3.2, M4.6, M4.13, M6.6) and inflam-
mation (M4.2, M5.1, M6.13) modules. Cluster C2 comprised 31
patients with a signature qualitatively similar to C1, but
quantitatively dimmer as supported by the lower mean MDTH
(973). Cluster C3 regrouped 12 patients with high MDTH (2,395)
and low inflammatory signature, but over-expression of modules
linked to erythropoiesis (M2.3, M3.1, M4.4, M6.18) and
hematopoiesis (M5.3). C1 and C3 both displayed significant
down-regulation of transcripts linked to B and T cells (Figure S5).
Gene level analysis (Figure S6A) combined with PANTHER [19]
ontology ranking (http://www.pantherdb.org) supported this
observation as heme biosynthesis (Figure S6B) and porphyrin
metabolism (Figure S6C) were the most enriched pathways in C3
versus C1. The top 100 transcripts differentially expressed between
C1 and C3 are displayed in Table S4 and Figure S6D. Finally,
cluster C4 was comprised 18 patients with lower mean MDTH
(699). Interestingly, 11 of them displayed an IFN signature,
although only one patient had concomitant CMV infection
detected by viral culture.
The median values for different clinical findings and laboratory
parameters were calculated for each cluster (Figure 2E, Table S5).
In addition, we assessed whether the differences observed at the
modular level were related to the time of sample collection in
relation to the length of stay (draw index). Cluster C1 displayed a
lower draw index, indicating that blood samples were collected at
an earlier stage of hospitalization. Patients from C1 required a
longer duration of hospitalization than other patients. Addition-
ally, patients from C1 had significantly higher CRP, WBC,
neutrophil and monocyte counts. Thus, these routine laboratory
markers of inflammation corroborated the over-expression of
myeloid and inflammatory modules.
The C3 patients showed decreased hemoglobin, hematocrit,
and MCHC (Figure S6F, Table S5), suggesting an anemic state
that might trigger erythropoiesis as indicated by the signature. The
C3 erythropoietic signature overlapped with transcripts from
CD71+ early erythroid precursors [20] (Figure S6D).
Then, we analyzed how infection site, clinical presentation, and
type of bacterial strain were distributed among clusters (Figure 2F,
Table S6). All patients in cluster C1 had invasive or disseminated
disease, and a higher proportion of patients with pneumonia.
Clusters C4 and TQ (transcriptionally quiescent) included most
patients with skin and soft tissue abscesses, confirming the
association between low MDTH and mild presentation.
Bacterial factors had limited influence on the host
expression profiles
Finally, to determine whether heterogeneityinbacterial virulence
factors was associated with clustering patterns, the isolates from 63
patients were characterized (Figure S1). The majority (87%) of
isolates tested were PVL-positive. Both clusters C1 and C3
displayed a higher percentage of MRSA isolates (100% and 92%)
than the overall mean (67%), suggesting that clones of CA-MRSA
USA300 might induce a stronger host response than the currently
circulating MSSA clones. No difference in other bacterial
characteristics such as agr locus type or genetic relatedness was
observed between the four clusters. (Table 3, Table S7).
Elements of the molecular signature correlate with
laboratory parameters
We then asked whether patient’s molecular profiles correlated
with clinical laboratory parameters commonly used to assess
clinical disease status (Table S8). The MDTH positively correlated
with neutrophil counts, white blood cell counts, C-reactive protein,
band neutrophil counts, red blood cell distribution width, and
monocyte counts. MDTH inversely correlated with relative
lymphocyte counts, red blood cell count, hemoglobin concentra-
tion, mean corpuscular hemoglobin (MCH) concentration, and
hematocrit. Correlations were assessed on a module-by-module
basis (Figure 3A). Inflammatory modules positively correlated with
neutrophil counts, CRP and WBC while modules linked to
adaptive immunity negatively correlated with these parameters.
Hematopoiesis (M3.3) and cell cycle (M6.11) modules correlated
Table 2. Infection localization and clinical presentation distribution for training and test sets.
Definition
Training
(n=40)
Test
(n=59)
Total
(n=99)
Localization Local SST abscess or cellulitis 0 (0%) 10 (16.9%) 10 (10%)
Invasive Bacteremia, pneumonia,
osteomyelitis, meningitis
33 (82.5%) 41 (69.5%) 74 (74.8%)
Disseminated Bacteremia+2 sites of infection 5 (12.5%) 8 (13.6%) 13 (13%)
Unclassified 2 (5%) 0 (0%) 2 (2%)
Clinical
Presentation
SST Abscess Skin abscess, no bacteremia 0 (0%) 10 (16.9%) 10 (10%)
Osteoarticular Bacteremia and osteomyelitis or
suppurative arthritis
29 (72.5%) 27 (45.8%) 56 (56.6%)
Pneumonia 6 (15%) 5 (8.5%) 11 (11.1%)
Unclassified 5 (12.5%) 17 (28.8%) 23 (23.2%)
doi:10.1371/journal.pone.0034390.t002
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correlations between clinical nodes and molecular nodes are
summarized as a network (Figure 3B).
Time of blood sampling, infection dissemination, and
clinical presentation influence the transcriptional
signature
To determine whether the type and dissemination of the disease
as well as time of sample collection influenced the genomic
fingerprint, a supervised analysis was conducted to compare
transcriptional signatures according to: 1) time in the course of the
infection as defined by draw index quarters; 2) infection site; and 3)
types of invasive clinical presentations. Three myeloid lineage and
three inflammation related modules were differentially regulated
from quarter to quarter (Figure 4A). The MDTH also displayed a
decreasing trend (Figure 4B) that was paralleled by the decrease in
CRP (Figure 4C). MDTH increased as the infection became more
disseminated (Figure 4D), which was most evident during the first
Figure 2. Individual analysis identifies heterogeneous components of the blood signature to S. aureus.A .Column scatter plot
representing the distribution of individual molecular distance to health (MDTH) in healthy controls and S. aureus patients. The list of all transcripts
composing the modules was used as reference to calculate individual MDTH (***: p,0.001, Mann-Whitney). Horizontal bars represent the group
median. Patients with MDTH within healthy range (n=25) were categorized as transcriptionally quiescent (TQ) and represented in grey. B.
Unsupervised hierarchical clustering of the 10,972 transcripts expressed in at least one of the 143 samples (2-fold normalized, 100 difference in raw
data) from the combined training and test sets. C. The modular signature was derived for individual transcriptionally active patients (n=74) as
compared to the median of the healthy control group for the corresponding patient set (training or test). Four major clusters (C1 through C4) of
patients were obtained by K-means clustering and reorganized into a single heatmap, with modules in rows and patients in columns. Molecular
distance to health for individual samples is represented as a line chart on top of the heatmap. D. Zoom on modules with specific over-expression
patterns across the four clusters. E. MDTH and clinical lab measurements distribution by cluster. Five or six-group non-parametric ANOVA (Kruskal-
Wallis) with Dunn’s post-hoc test was applied. (*: p,0.05, **: p,0.01, ***: p,0.001). F. Bar charts representing the percent distribution of infection
localization, clinical presentation and bacterial strain for the five clusters of patients identified.
doi:10.1371/journal.pone.0034390.g002
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was paralleled by increased CRP and hospitalization duration
(Table S9).
Next, we analyzed patients according to the type of clinical
presentation. Patients with pneumonia had a higher median
MDTH than patients with osteoarticular infections as well higher
WBC, neutrophil and monocyte counts (Figure 4E, Figure S8A,
and Table S10).
Patients with osteoarticular infections display transcripts
linked to activated blood coagulation that are not
present in patients with pneumonia
To assess transcriptional differences between patients with
distinct clinical presentations we selected nine patients with
osteoarticular infection and compared them to nine patients with
pneumonia matched for MDTH (Figure S8B). Eighteen healthy
controls (nine from each training and test sets) were used as
reference. Module fingerprints identified over-expression of the
coagulation cascade (M1.1) and platelet adhesion (M6.14) in
patients with osteoarticular infection but not pneumonia
(Figure 5A). From the 385 genes differently expressed
(Figure 5B), PANTHER analysis for pathway enrichment
(Figure 5C) identified blood coagulation as the most significant
pathway over-expressed in osteoarticular infection, and cholesterol
biosynthesis over-expressed in pneumonia. No significant correla-
tions were observed between bacterial isolates (Table S7) and
clinical presentation.
Discussion
This study is the first analysis of whole blood transcriptional
profiles in pediatric patients with acute community-associated S.
aureus infections. Both conserved and heterogeneous elements of
the transcriptional signature were identified, which correlate with
time elapsed since hospitalization, bacterial dissemination, and the
type of clinical presentation. Supporting our earlier study on
PBMC [21], the whole blood signature was characterized by
significant over-expression of myeloid lineage and inflammation
transcripts, and under-expression of lymphoid lineage transcripts.
This may reflect the large expansion of circulating neutrophils and
monocytes during the acute phase of infection.
While all patients share a global signature to S. aureus infection,
analysis of fingerprints of individual patients revealed heteroge-
neous elements of the molecular signature. The major transcrip-
tional patterns identified included a pro-inflammatory myeloid
signature, linked to sampling early in the course of infection, high
neutrophil and monocyte counts, and elevated CRP (C1). Some
patients displayed an erythropoiesis fingerprint with limited
myeloid components (C3), which likely represents an increased
release of hematopoietic precursors from the bone marrow during
acute infection [22]. This erythropoiesis signature was observed in
systemic onset juvenile idiopathic arthritis (SOJIA) [20] and was
proposed to reflect the expansion of immature precursor cells and
ineffective erythropoiesis. The latter results in accumulation of
iron in tissues [23], which supports bacterial survival. It was
suggested that erythropoietin (EPO) inhibits NF-kB and TNFa-
mediated pro-inflammatory pathways [24], which could explain
Table 3. Distribution of bacterial isolate characteristics by infection localization, presentation and cluster.
Infection Dissemination Clinical Presentation Cluster
Fisher’s Exact
Test
Fisher’s Exact
Test
Fisher’s Exact
Test
Table
Probability (P) Pr,=P
Table
Probability (P) Pr,=P
Table
Probability (P) Pr,=P
# Patients - - - - - -
# Isolates - - - - - -
Antibiotic Resistance MRSA 0.07 .0.05 0.06 .0.05 0.0016 .0.05
MSSA
Agr Type agr I 0.08 .0.05 0.11 .0.05 2.60E-03 .0.05
agr II
agr III
Genetic Relatedness USA 200 0.01 .0.05 0.02 .0.05 2.20E-07 .0.05
USA 300
USA 400
USA 500
USA 700
USA 1100
Toxin Production PVL + 0.12 .0.05 0.16 .0.05 1.40E-02 .0.05
2
TSST/SEA/SEB/SEC + 0.15 .0.05 0.17 .0.05 0.028 .0.05
2
SEH/SEG + 0.09 .0.05 0.18 .0.05 0.0019 .0.05
2
TQ: Transcriptionally Quiescent.
doi:10.1371/journal.pone.0034390.t003
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This could represent a bacterial survival mechanism, whereby
increased erythropoiesis would prevent the development of an
adequate pro-inflammatory response and subsequent bacterial
clearance. Despite increased numbers of neutrophils, we did not
detect consistent changes in transcripts linked to the interferon
response, as previously observed in patients with active pulmonary
tuberculosis [12]. Fifteen out of 99 patients displayed over-
expression of the three IFN modules but tested negative for
concomitant viral infections. It may reflect IFN activation to
counter arrest the bacteria-induced pro-inflammatory milieu [25]
in the later stages of infection.
Currently, there are no established laboratory markers that
either objectively define the extent of clinical disease severity in
patients with S. aureus infections or monitor the spread of the
infection to multiple organs [8]. Transcriptional profiling high-
lighted global quantitative differences between patients with local
or disseminated disease, supporting the value of microarrays and
the quantitative MDTH genomic score to monitor the spread of
infection.
Additionally, the signatures provided unique transcriptional
information on the pathogenesis of different clinical syndromes.
Patients with osteoarticular infections displayed over-expression of
transcripts linked to blood coagulation, a finding possibly related
with the increased systemic coagulation and deep venous
thrombosis observed in patients with musculoskeletal infections
[26]. Additionally, patients with pneumonia displayed over-
expression of genes involved in cholesterol synthesis, which might
be involved in neutrophil recruitment to the lung [27].
Importantly, the location and extent of disease dissemination
impacted transcriptional profiles to a greater extent than
molecular characteristics of the S. aureus strains. This suggests that
either: 1) the early innate response is directed towards features of S.
aureus conserved across strains; 2) the human response is
specifically tailored to the infection site; 3) staphylococcal gene
expression differs based on the site of disease.
Despite the qualitative variability of the host response, the
intensity of the signature decreases as patients get closer to
discharge, regardless of the localization of the infection or the type
of clinical presentation, suggesting that this assay has potential to
monitor the clinical course of infection. Future studies should focus
on the diagnostic and prognostic value of this approach in
identifying patients at risk for infection dissemination and
eventually determine its value in guiding therapeutic decisions.
Materials and Methods
Ethics Statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. The study was approved by the
Institutional Review Boards of the University of Texas South-
western Medical Center and Children’s Medical Center of Dallas
(IRB #0802-447) and Baylor Institute of Immunology Research
(BIIR, IRB # 002-141). Informed written consent was obtained
from legal guardians and informed assent was obtained from
patients 10 years of age and older prior to any study-related
procedure.
Patient characteristics
Blood samples from 99 patients hospitalized with community-
acquired S. aureus infection and 44 healthy controls were collected
in tempus tubes (Applied Biosystems, PN 4342792). Patients
represented the clinical spectrum of acute S. aureus infection,
including skin and soft tissue infection, bacteremia, osteomyelitis,
suppurative arthritis, pyomyositis, pneumonia with empyema, and
disseminated disease defined as bacteremia and the involvement of
2 different anatomical sites. Patients with a diagnosis of toxic shock
syndrome, polymicrobial infections, or treated with corticosteroids
in the preceding four weeks were excluded. Viral direct fluorescent
antibody testing and/or culture of the nasopharynx was performed
in all patients and healthy controls to exclude concomitant viral
infections. Patient demographic data and clinical characteristics
are summarized in Table S1 and Table S2. The median duration
of hospitalization was ten days (range: 1–98 days). The median
time from patient hospitalization to blood sample acquisition was
five days (range: 1–35 days).
Figure 3. Specific module subsets correlate with laboratory
results. A. Heatmap representing correlation (Spearman R) between
module percent expression in columns and continuous laboratory
parameters in rows. Hierarchical clustering (Euclidian distance) was
applied in both dimensions. B. Connection network representing
correlation between molecular nodes (modules) in blue and clinical
nodes (laboratory parameters) in green. Spearman R correlation greater
than 0.3 are represented.
doi:10.1371/journal.pone.0034390.g003
Blood mRNA Profiles in S. aureus Infection
PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e34390Patient classification
The study cohort of 99 patients and 44 healthy controls was
divided into independent training (40 patients, 22 healthy controls)
and test sets (59 patients, 22 healthy controls) (Table 1). Patients
were categorized according to three schemes (Table 2) based on
assessment by an independent clinician who was blinded to the
transcriptional data: i) by localization of infection, defined as local
(n=10), invasive (n=74) or disseminated (n=13); ii) by clinical
presentation, separating patients with skin and soft tissue infection
with negative blood culture (n=10), patients with osteoarticular
infections (n=56), and patients with pneumonia (n=11).
Sampling time: Draw index and hospitalization quarter
This cross-sectional study included samples drawn at different
days during hospitalization. To assess the influence of the time the
sample was obtained during the course of the infection we
calculated a draw index, a numeric score between 0 and 1
calculated as the ratio of the blood draw day over the duration of
hospitalization. Accordingly, samples were classified according to
the hospitalization quarter (0#Quarter 1,0.25#Quarter
2,0.50#Quarter 3,0.75#Quarter 4).
Characterization of Bacterial Isolates
Bacterial isolates from 63 patients were recovered from blood
culture, synovial fluid, or abscesses. Single colonies were selected
Figure 4. Patient signature varies with blood draw index, dissemination and clinical presentation. A. Patients were organized in four
quarters Q1 through Q4 based on blood draw index (ratio draw day/hospitalization duration). A low draw index signifies proximity to hospital
admission while a high draw index signifies proximity to discharge. Transcripts differently expressed between the four draw index quarters were
selected by non-parametric ANOVA (Kruskal-Wallis, p,0.01, Benjamini-Hochberg false discovery rate) and represented as a heatmap (red, yellow,
blue). The same statistical filter was applied at the module level (red, white, blue heatmap below). Individual MDTH was represented above as a line
chart. B. Column scatter plot of individual MDTH per blood draw index quartile. Horizontal bars represent group median. Non-parametric ANOVA
(Kruskal-Wallis) with Dunn’s post-hoc test was applied. C. Non-linear regression model (one-phase decay) of MDTH (left Y-axis) and CRP (right Y-axis)
as a function of blood draw index. D. Column scatter plot of individual MDTH per infection localization group. E. Column scatter plot of individual
MDTH per clinical presentation group. Horizontal bars represent the median value for each group. Non-parametric ANOVA (Kruskal-Wallis) with
Dunn’s post-hoc test was applied between patient groups.
doi:10.1371/journal.pone.0034390.g004
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isolates were tested for methicillin resistance by mecA PCR.
SCCmec typing of MRSA isolates was performed by classifying
the ccr and mec complexes [28]. agr locus typing was performed
and genetic relatedness was determined by repetitive-element,
sequence-based PCR (rep-PCR). Gene encoding of toxins was
detected by traditional PCR [28,29] (Figure S1, Table S3).
RNA Preparation and Microarray Hybridization
RNA was processed as described elsewhere [12]. The data are
deposited in the NCBI Gene Expression Omnibus (GEO, http://
www.ncbi.nlm.nih.gov/geo, GEO Series accession number
GSE30119).
Batch Correction
To prevent batch effect between training and test sets, principal
variance component analysis (PVCA) was conducted using JMP
Genomics (SAS Institute, Cary, NC) to identify sources of batch
effect. Cohort number accounted for 58% of the variability
observed (Figure S2A) and scatter plot visualization (Figure S2B)
with ellipsoids (Figure S2C) revealed strong segregation of samples
based on cohort. The batch correction algorithm CombatR [30]
was used on the cohort variable to reduce its contribution to the
global variance. The batch effect from the cohort was reduced to
approximately 0% (Figure S2D, Figure S2E and Figure S2F).
Module Framework Development
This analysis strategy has been described elsewhere [16]. A set
of 62 transcriptional modules derived from 410 whole blood gene
expression profiles was applied to the dataset described herein.
Modules were annotated with Ingenuity Pathway Analysis (IPA)
(Ingenuity Systems, Redwood City, CA), Pubmed, iHOP, and
Novartis Gene Atlas (http://biogps.gnf.org) databases. Module
transcript content and annotations are available online (http://www.
biir.net/public_wikis/module_annotation/V2_Trial_8_Modules).
Module-level Analysis
Gene expression levels were compared between patients and
healthy controls on a module-by-module basis. The percentage of
transcripts showing significant differences (Mann-Whitney,
p,0N05) in expression was used as an indicator of module activity.
Modules containing transcripts with increased expression were
Figure 5. The osteoarticular infection signature displays increased blood coagulation. We compared the transcriptional signatures from
patients with pneumonia and patients with osteoarticular infections. To properly balance osteoarticular and pneumonia groups, patients with
pneumonia with a draw index less than 0.75 (nine patients) were selected (active disease). Nine patients with osteoarticular infection were selected
with matching MDTH so that global quantitative signature was equivalent between the two groups. Nine healthy controls were selected from the
training and nine from the test set (18 healthy controls in total) as reference. A. Top left panel: mean module map for the nine patients with
osteoarticular infections compared to the 18 healthy controls. Bottom left panel: mean module map for the 9 patients with staphylococcal
pneumonia compared to the 18 healthy controls. Top right panel: substraction map of osteoarticular infections minus pneumonia. Only differences
greater than 40% are represented. Bottom right panel: Annotation legend for modules identified. B. Heatmap representing genes differentially
expressed (t-test, ,0.05, no correction) between osteoarticular infections and pneumonia (hierarchical clustering, Pearson). 190 genes were
upregulated 1.5-fold or more in osteoarticular infections versus pneumonia and healthy controls. 185 genes were upregulated 1.5-fold or more in
pneumonia versus osteoarticular infections and healthy controls. C. Area chart representing PANTHER comparison for pathway enrichment between
the two lists from C.
doi:10.1371/journal.pone.0034390.g005
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decreased expression were represented on a blue scale. Modules
with 15% or less transcripts with significant change in abundance
compared to healthy controls were not displayed.
Supporting Information
Figure S1 Characterization of the 63 clinical bacterial
isolates. A. Pie charts representing distribution of methicillin
resistance, agr locus type and genetic relatedness for the 63
bacterial isolates isolated from culture. B. Bar chart representing
the percentage of isolates positive for the measured toxins.
(TIF)
Figure S2 Batch correction for the two cohorts of
patients used as training and test sets. A. Pie chart of
percent contribution of individual parameter to variance from
principal variance component analysis (PVCA) before CombatR
correction. B. Scatter plot representing the segregation of sample
by cohort before CombatR correction. C. Elliptical fit of scatter
plot data from B. D. Pie chart of individual parameter’s percent
contribution to variance from PVCA after CombatR correction
for cohort. E. Scatter plot representing the segregation of sample
by cohort after CombatR correction. F. Elliptical fit of scatter plot
data from E.
(TIF)
Figure S3 Determination of the best number of K-
means clusters from individual patient module expres-
sion. An appropriate K was chosen for clustering this dataset
using an information theoretic approach called the ‘‘jump
method’’. First, the data was clustered for all K 1 to 5, inclusive.
A. The distortion of each clustering was calculated. In this
instance, we chose to approximate the covariance matrix with the
identity matrix so the distortion is simply the mean squared error.
B. Next, the transformed distortion for each K is calculated by
raising the distortion to a power of -(# of dimensions/2). C.
Finally, the Jump at each K is calculated as follows: Jump_K=-
TransformedDistortion_K - TransformedDistortion_K-1. The
maximum Jump is used to select K, in this case, K=4.
(TIF)
Figure S4 Module signature per cluster of patients.
Module signature was derived for each cluster of molecularly
active patients (C1 to C4) and the group of transcriptionally
quiescent (TQ) patients as compared to the combined 44 healthy
controls.
(TIF)
Figure S5 Cluster of under-expressed modules in the 74
molecularly active patients with S. aureus infection.
(TIF)
Figure S6 Cluster C3 displays an erythropoiesis signa-
ture. A. Heatmap representing the 680 transcripts differentially
expressed between clusters C1 and C3. Statistical comparison
between C1 and C3 yielded 680 differentially expressed transcripts
(non-parametric test, a=0N01, Benjamini-Hochberg multiple
testing correction, 26fold change). Of these, 246 transcripts were
over-expressed in C1 and 434 transcripts were over-expressed in
C3. B. Area chart representing pathways significantly enriched
(p,0N05) in the two gene lists identified in A according to
PANTHER (http://www.pantherdb.org). C. Area chart repre-
senting biological processes significantly enriched (p,0N01) in the
two gene lists identified in A according to PANTHER. D.
Heatmap representing the top 100 transcripts over or under-
expressed in C3 versus C1. E. Heatmap representing the
expression of 87 transcripts specifically expressed in CD71+
erythroid precursors in the four patient clusters. F. Scatter plot of
various CBC measurements for patients organized by transcrip-
tionally active clusters C1 through C4 and transcriptionally
quiescent (TQ) patients. The green rectangle represents the range
of values for healthy children (two months to 18 years) recorded at
Childrens Hospital, Dallas.
(TIF)
Figure S7 S. aureus patient molecular distance to health
varies with infection localization, clinical presentation
and blood draw index. A. MDTH as a function of blood draw
index for patients grouped by disease localization. B. MDTH as a
function of blood draw index for patients grouped by disease
presentation. A non-linear regression statistical model (one-phase
decay) was applied.
(TIF)
Figure S8 Selection of osteoarticular infection and
pneumonia patients for comparison. A. Dot plot of
neutrophil counts for patients grouped by clinical presentation.
Horizontal bars represent the median value for each group. Non-
parametric ANOVA (Kruskal-Wallis) with Dunn’s post-hoc test
was applied. B. Column scatter plot of individual MDTH for
patients selected for comparison. Horizontal bars represent the
median value for each group. Non-parametric testing (Mann-
Whitney) was applied between the two groups of patients.
(TIF)
Table S1 Training set subjects characteristics.
(XLS)
Table S2 Test set subjects characteristics.
(XLS)
Table S3 Characterization of bacterial isolates from 63
patients.
(XLS)
Table S4 Top 50 over-expressed genes in C1 vs. C3 (left)
and C3 vs. C1 (right).
(XLS)
Table S5 Clinical parameters for patients grouped by
transcriptional clustering.
(XLS)
Table S6 Disease localization, clinical presentation and
strain distribution by cluster.
(XLS)
Table S7 Distribution of bacterial isolates characteris-
tics by infection localization, clinical presentation and
cluster.
(XLS)
Table S8 Spearman correlations between molecular
distance to health (MDTH) and clinical laboratory
parameters.
(XLS)
Table S9 Clinical parameters for patients grouped by
infection localization.
(XLS)
Table S10 Clinical parameters for patients grouped by
clinical presentation.
(XLS)
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